Literature DB >> 22350543

Evaluation and treatment of children and adolescents with psychotic symptoms.

Sibel Algon1, James Yi, Monica E Calkins, Christian Kohler, Karin E Borgmann-Winter.   

Abstract

In recent years, there have been increasing efforts to develop early detection and prevention strategies for patients at risk of the development of psychotic disorders. These efforts have led to improved recognition and characterization of psychotic symptoms in youth. This review focuses on the evaluation of children and adolescents with psychotic symptoms who are experiencing functional impairment but who do not meet current criteria for schizophrenia. For this article, emphasis is placed on the evaluation of symptoms, differential diagnosis, and consideration of potential interventions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22350543      PMCID: PMC3500659          DOI: 10.1007/s11920-012-0258-y

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  72 in total

Review 1.  Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis.

Authors:  Diana O Perkins; Hongbin Gu; Kalina Boteva; Jeffrey A Lieberman
Journal:  Am J Psychiatry       Date:  2005-10       Impact factor: 18.112

Review 2.  Assessment of adolescents at risk for psychosis.

Authors:  Karin Borgmann-Winter; Monica E Calkins; Kathryn Kniele; Raquel E Gur
Journal:  Curr Psychiatry Rep       Date:  2006-08       Impact factor: 5.285

3.  Ethics of the early intervention in the treatment of schizophrenia.

Authors:  Pavo Filaković; Dunja Degmecić; Elvira Koić; Domagoj Benić
Journal:  Psychiatr Danub       Date:  2007-09       Impact factor: 1.063

Review 4.  Psychosis treatment prior to psychosis onset: ethical issues.

Authors:  T H McGlashan
Journal:  Schizophr Res       Date:  2001-08-01       Impact factor: 4.939

5.  The role of treatment delay in predicting 5-year outcomes in an early intervention program.

Authors:  R M G Norman; R Manchanda; D Windell; R Harricharan; S Northcott; L Hassall
Journal:  Psychol Med       Date:  2011-07-18       Impact factor: 7.723

6.  Calcium: pacesetting the periodic psychoses.

Authors:  J S Carman; R J Wyatt
Journal:  Am J Psychiatry       Date:  1979-08       Impact factor: 18.112

Review 7.  Quinolones: review of psychiatric and neurological adverse reactions.

Authors:  Ana M Tomé; Augusto Filipe
Journal:  Drug Saf       Date:  2011-06-01       Impact factor: 5.606

Review 8.  Neuropsychiatric manifestations in pediatric systemic lupus erythematosus: a 20-year study.

Authors:  H H Yu; J H Lee; L C Wang; Y H Yang; B L Chiang
Journal:  Lupus       Date:  2006       Impact factor: 2.911

9.  Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.

Authors:  G Paul Amminger; Miriam R Schäfer; Konstantinos Papageorgiou; Claudia M Klier; Sue M Cotton; Susan M Harrigan; Andrew Mackinnon; Patrick D McGorry; Gregor E Berger
Journal:  Arch Gen Psychiatry       Date:  2010-02

10.  Zinc, manganese, calcium, copper, and cadmium level in scalp hair samples of schizophrenic patients.

Authors:  Ashrafur Rahman; Mohammad Abul Kalam Azad; Iqbal Hossain; M M A Shalahuddin Qusar; Wasimul Bari; Farida Begum; S M Imamul Huq; Abul Hasnat
Journal:  Biol Trace Elem Res       Date:  2008-09-23       Impact factor: 3.738

View more
  5 in total

Review 1.  Is prevention a realistic goal for schizophrenia?

Authors:  Christian Kohler; Karin E Borgmann-Winter; Irene Hurford; Eli Neustadter; James Yi; Monica E Calkins
Journal:  Curr Psychiatry Rep       Date:  2014-04       Impact factor: 5.285

2.  Presence of Alcohol and Drugs in Hispanic Versus Non-Hispanic Youth Suicide Victims in Miami-Dade County, Florida.

Authors:  Daniel Castellanos; Jennifer Ellyn Kosoy; Karla Diaz Ayllon; Juan Acuna
Journal:  J Immigr Minor Health       Date:  2016-10

3.  Psychological interventions for psychosis in adolescents.

Authors:  Soumitra S Datta; Rhea Daruvala; Ajit Kumar
Journal:  Cochrane Database Syst Rev       Date:  2020-07-03

4.  Cariprazine Safety in Adolescents and the Elderly: Analyses of Clinical Study Data.

Authors:  Balázs Szatmári; Ágota Barabássy; Judit Harsányi; István Laszlovszky; Barbara Sebe; Mónika Gál; Kazushi Shiragami; György Németh
Journal:  Front Psychiatry       Date:  2020-03-03       Impact factor: 4.157

5.  School Counselors' Recognition of the Ultra-High Risk for Psychosis.

Authors:  Ju-Yeon Lee; Young-Chul Chung; Jae-Min Kim; Il-Seon Shin; Jin-Sang Yoon; Sung-Wan Kim
Journal:  Psychiatry Investig       Date:  2018-02-22       Impact factor: 2.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.